Literature DB >> 8090259

Prevalence of movement disorders in elderly community residents.

S Moghal1, A H Rajput, C D'Arcy, R Rajput.   

Abstract

We studied movement disorders (MD) in community residents of Saskatchewan aged > or = 65 years. A representative sample of 70 individuals had detailed neurological evaluation. Those who had definite and possible MD at first examination had a second neurological assessment by a senior neurologist. The most prevalent MD was essential tremor (ET) (14%) followed by Parkinson's disease (PD) (3%). The marked difference in prevalence ratios for PD and ET are attributed to: (a) higher incidence of ET in the general population; (b) a greater possibility that most, if not all, ET cases would reside in the community whereas a sizable proportion of elderly PD cases may be institutionalized, and (c) shortened survival in PD but a normal life expectancy in ET.

Entities:  

Mesh:

Year:  1994        PMID: 8090259     DOI: 10.1159/000110376

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  35 in total

1.  Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease.

Authors:  S M Kulich; C T Chu
Journal:  J Neurochem       Date:  2001-05       Impact factor: 5.372

2.  Rotigotine transdermal system for perioperative administration.

Authors:  A D Korczyn; H Reichmann; B Boroojerdi; H-J Häck
Journal:  J Neural Transm (Vienna)       Date:  2006-12-21       Impact factor: 3.575

Review 3.  α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.

Authors:  Jason P Covy; Benoit I Giasson
Journal:  Neurotoxicology       Date:  2011-01-14       Impact factor: 4.294

Review 4.  [Anaesthesia in patients with Parkinson's disease].

Authors:  A Kalenka; J Hinkelbein
Journal:  Anaesthesist       Date:  2005-04       Impact factor: 1.041

5.  Genetic mouse models of essential tremor: are they essential?

Authors:  Joseph Jankovic; Jeffrey L Noebels
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 6.  The clinical approach to movement disorders.

Authors:  Wilson F Abdo; Bart P C van de Warrenburg; David J Burn; Niall P Quinn; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2010-01       Impact factor: 42.937

7.  Variant in the sequence of the LINGO1 gene confers risk of essential tremor.

Authors:  Hreinn Stefansson; Stacy Steinberg; Hjorvar Petursson; Omar Gustafsson; Iris H Gudjonsdottir; Gudrun A Jonsdottir; Stefan T Palsson; Thorlakur Jonsson; Jona Saemundsdottir; Gyda Bjornsdottir; Yvonne Böttcher; Theodora Thorlacius; Dietrich Haubenberger; Alexander Zimprich; Eduard Auff; Christoph Hotzy; Claudia M Testa; Lisa A Miyatake; Ami R Rosen; Kristleifur Kristleifsson; David Rye; Friedrich Asmus; Ludger Schöls; Martin Dichgans; Finnbogi Jakobsson; John Benedikz; Unnur Thorsteinsdottir; Jeffrey Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-02-01       Impact factor: 38.330

8.  Essential tremor might be less frequent than Parkinson's disease in North Israel Arab villages.

Authors:  Amir Glik; Magdalena Masarwa; Amin Abuful; Amar Deeb; Rosa Strugatsky; Lindsay A Farrer; Robert P Friedland; Rivka Inzelberg
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

Review 9.  Glutamate receptors as therapeutic targets for Parkinson's disease.

Authors:  Kari A Johnson; P Jeffrey Conn; Colleen M Niswender
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

Review 10.  Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.

Authors:  Vladimir N Uversky; David Eliezer
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.